Orthomolecular Medicine or Supplements? Why the Dose Changes Everything

Two people tell you on the same evening that they take vitamin D. One takes 1,000 International Units from the drugstore, because the sun goes missing in winter. The other takes fifty times that, under medical supervision, with monthly blood draws and a strict diet alongside it.

Both say the same sentence: "I take vitamin D."

And both are right. They are just talking about two completely different things. One is a supplement. The other is an experimental therapeutic approach that can become dangerous without monitoring. There is no nuance between the two. There is a line between categories.

That line is almost never drawn cleanly online. And that is why so many conversations about supplements go around in circles.

Two doses, one substance, two different worlds

Picture water. One glass is refreshment. Two liters within an hour can shift your salt balance in a dangerous direction. Same substance, same chemical formula, two completely different biological situations.

With nutrients the same principle applies, only almost nobody talks about it. The reason is simple. The word on the tub is vitamin, and that word sounds harmless. It sounds like fruit.

Pharmacologically it is not. Above a certain amount, a vitamin no longer behaves like a building block. It behaves like a signalling substance that reaches into control loops. Then there is a dose response relationship, there is a working range, and there is an upper limit. That is exactly what makes something a medicine.

How big that difference can be was shown very elegantly by a group at the American health institutes, using vitamin C as their example.

And now you know why I never start a consultation by asking whether somebody takes supplements, but always by asking how much of what, and why.

Where the word comes from: Linus Pauling and a term with a big promise

When you read "orthomolecular medicine", you are reading a word one single person invented. And that person was not a physician.

Linus Pauling was a chemist. He received two Nobel Prizes, one for chemistry and one for peace, and he ranks among the most influential natural scientists of the twentieth century. In 1968 he published an essay in the journal Science titled "Orthomolecular psychiatry".

His idea was clearly stated. Ortho means right. Orthomolecular means: the right molecules in the right concentration. Pauling argued that the optimal concentration of the body's own substances in the brain could, in some people, lie far above what diet and genetics provide. He pointed out that psychological symptoms often appear long before physical ones when a vitamin runs short, and he proposed that local shortages could exist in the brain while blood values still look unremarkable.

I still find that thought interesting today. The idea that a tissue can be running short while the serum looks unremarkable is not esoteric. For magnesium it is described that the serum value reflects the tissue store only to a limited degree, because the body regulates the blood level tightly. With vitamin B12 the same problem is approached through functional markers. Whether a whole blood measurement allows better everyday decisions than the standard determination is not scientifically settled. I use it as additional information alongside history taking and standard labs, not as a superior replacement.

The second half of Pauling's story is less comfortable. And I am telling it here on purpose.

The vitamin C controversy and the Mayo trials

In the 1970s Pauling turned to cancer together with the Scottish surgeon Ewan Cameron. In 1976 the two published a paper in the Proceedings of the National Academy of Sciences that drew a lot of attention.

The Mayo Clinic then tested this claim twice, double blind and randomised. Both times the result came out negative.

In 1979, 150 people with advanced cancer received either 10 grams of vitamin C daily or a placebo. No difference showed up in symptoms, general condition, appetite, weight or survival. The survival curves lay practically on top of each other.

In 1985 the same group repeated the experiment with one decisive detail: this time the 100 participants with advanced bowel cancer had received no prior chemotherapy, because that had been exactly Pauling's objection to the first trial. Here too, no advantage over placebo appeared.

The story has a third layer, though, and that is why the topic never quite went away. Cameron had given part of his vitamin C intravenously. The Mayo trials gave tablets only. The pharmacokinetic work from the first section shows that these produce completely different blood levels. Padayatty and colleagues explicitly concluded that the role of vitamin C in cancer treatment cannot be judged on the basis of trials using oral dosing alone.

That is not a rehabilitation of the original thesis. The authors of the pharmacokinetic paper noted themselves that their high dose values come from a calculation model and that patient data to confirm them are missing, precisely in people with cancer. No statement about benefit or harm of intravenous use in a cancer illness can be derived from that.

And now you know why I use the term itself rather sparingly, and prefer to speak of targeted, time limited, lab guided nutrient therapy.

Covering your needs: what the tubs from the online shop can do, and what they cannot

You know the feeling in the drugstore. Shelf metres full of tubs, big numbers, words like high dose, depot, complex, premium. And somewhere inside you the quiet question: if all of this is so strong, why do I notice nothing?

The answer is usually unspectacular. Legally these products are foods, not medicines. Their job is to supplement a normal diet. They are not allowed to treat a disease, and they are not even allowed to promise it.

That is not a weakness of the product, that is its definition. A tub of vitamin D with 1,000 International Units is made to fill a supply gap in winter. It is not made to influence an autoimmune condition. Buy the one and expect the other, and you will be disappointed.

What helps is a clear separation between three orders of magnitude that you can hold in mind while reading any label.

Two numbers make this concrete. For vitamin D the European Food Safety Authority confirmed the tolerable upper intake level of 100 micrograms per day for adults in 2023, which is 4,000 International Units. For vitamin B6 the same value sits at 12 milligrams per day. These numbers are not a recommendation, they are a ceiling for continuous intake without medical supervision.

One point matters for context: for vitamin B6 the EFSA found no value above which side effects reliably appeared in studies. It derived a reference point of 50 milligrams per day from a case control study and applied a safety factor to it, because high doses can take a long time to become noticeable. That is caution cast into numbers.

And now you know why the first sensible action is almost never buying a capsule, but taking a measurement.

The vitamin D example: from 800 IU to the Coimbra protocol

No nutrient shows the difference between covering your needs and high dose therapy as clearly as vitamin D. That is why I almost always explain the principle with this example.

On one side stand the usual doses for covering requirements, mostly in the range of around 800 to 2,000 International Units daily. That is the order of magnitude sold in German drugstores and online shops, and it aims to bring the serum value into a customary range.

On the other side stands a procedure that comes from Brazil and has a small but active following in Germany: the so called Coimbra protocol, named after the neurologist Cícero Coimbra. It is used in autoimmune conditions, especially in multiple sclerosis.

I am describing it here in detail on purpose. Not because I recommend it, but because no other example shows so clearly what happens to a substance when you raise the dose by a factor of twenty or fifty.

A second publication from the same circle describes the approach: doses oriented to body weight, with parathyroid hormone in the blood as the central steering value. I deliberately give no daily amount converted to a body weight here, because an order of magnitude like that is only ever defensible under close medical supervision. The authors justify their approach with the hypothesis of an acquired vitamin D resistance, meaning a reduced responsiveness of the vitamin D receptor.

That hypothesis is mechanistically interesting. It is not proven. And at this point I want to be very clear.

What does it look like when high vitamin D doses in multiple sclerosis are tested not observationally but in a randomised way? There are data on that too, and they are sober.

That is the honest situation. A large controlled trial with 14,000 units daily missed its main endpoint. And at the same time there are observational data from a scene that works with far higher doses and reports unremarkable lab values. Both stand side by side, and neither finding invalidates the other.

What happens at the other end, when nobody is watching? There is literature on that too, and it is unambiguous.

And now you know why a sentence like "I take vitamin D" without a number behind it is medically almost meaningless.

Five nutrients that medicine regularly uses in high doses

Now comes the part both camps like to overlook. The idea that a nutrient could be used like a medicine in a high dose is not an invention of alternative medicine. In conventional medicine it is everyday practice.

The difference does not lie in the principle. It lies in the fact that these applications are narrowly defined: a particular condition, a particular dose, particular monitoring, a particular end point in time.

That last example deserves a closer look of its own, because it shows the limits of the concept so nicely.

And now you know why I consider neither "vitamins are harmless" nor "vitamins are nonsense" to be sensible sentences.

Why more is not the stronger version of enough

Maybe you know this feeling. You read about a nutrient, it sounds convincing, you order it. A few weeks later you read about a second one. After six months there is a small pharmacy on your kitchen table, and you no longer know exactly why what is there.

I say that without reproach. That dynamic is entirely understandable. It just rests on one thinking error: the idea that nutrients sit in separate drawers.

The body keeps no drawers. It runs control loops. Every nutrient has neighbours it shares a transport route with, or an enzyme, a binding site or a hormonal regulator. Turn one screw and you automatically move others with it.

The best known of these couplings are worth knowing before you dose anything yourself.

Zinc and copper share transport routes in the gut. Take high amounts of zinc over months and you can push copper uptake down. Vitamin D can shift the calcium balance, and magnesium is needed for vitamin D metabolism. For vitamin K2 it is discussed that it might co-influence the deposition of calcium in bone and vessel wall. That is mechanistically plausible, solid endpoint data in humans are thin so far. Single B vitamins in high doses can shift the pattern of the others, most famously with folic acid, which can mask a vitamin B12 deficiency in the blood count while the nerve damage goes on. Iron with silent inflammation present can be counterproductive, because in that situation the body can hold it back.

The vitamin with the best documented risk of its own is a different one, though. And of all things, it sits in almost every B complex.

And then there is the large, uncomfortable lesson from prevention research. It comes not from a niche, but from two of the biggest trials ever run on supplements.

And now you know why I would rather give three things on purpose than twelve on suspicion.

The four lenses: what a high dose shifts inside the system

In clinical psychoneuroimmunology we look at a symptom through four lenses. With the question of dose that is especially helpful, because a high amount rarely arrives only where we want it.

These four lenses explain why a serious high dose therapy always measures more than the one value it wants to influence. Look only at the vitamin D level and you do not see where the calcium is going. Raise only the zinc and you do not see what happens to the copper.

Real food first, and why topping up is still more often justified today

Before I talk about doses, I almost always talk about food in the consultation. Not out of loyalty to a principle, but because that is where the biggest levers sit.

Nutrients from real food of good origin never come alone. They come in a matrix of cofactors, fibre, secondary plant compounds and fats that helps steer their uptake. A capsule does not rebuild that matrix. It delivers one substance, isolated, in an amount that occurs in no food that way.

No supplement replaces food, sleep, movement, sunlight and relationship. That is not a calendar slogan, that is the sober order of effectiveness.

And even so, I consider targeted topping up more justified today than fifty years ago. Not because supplements have become fashionable, but because the conditions have changed.

And now you know why my first question is almost never which preparation, but what is on the plate and what is currently being used up.

Measuring instead of guessing: what serious supervision looks like

If I take one thing from the studies in this article, it is this: the difference between a sensible and a risky nutrient therapy rarely lies in the substance. It lies in four questions that should be answered beforehand.

There are well founded exceptions to the time limit. Vitamin B12 after stomach surgery, vitamin D in winter at our latitudes, long term substitution with a chronic absorption problem. These exceptions are exactly that: justified, documented and regularly reviewed. They are no free pass for the rest.

And now you know why I sometimes advise people against a capsule even though it would make sense in terms of content. When nobody is watching, the most important part is missing. That explicitly does not have to be with me. Your family practice can determine the baseline values and take over the monitoring, no specialised practice is needed for that. All that matters is that somebody does it at all.

Three levers you can put into practice today

No protocol, no brands, no weekly plans. Just three things that lie in your hands and that need no order to be placed.

And now you know why the most honest answer to "does orthomolecular medicine make sense" begins with a counter question: with which nutrient, in which person, at which dose, for which goal.

Common questions about orthomolecular medicine and high dose therapy

How this topic connects with the others

The dose question comes back with almost every nutrient. These paths lead onward.